<DOC>
	<DOCNO>NCT02532842</DOCNO>
	<brief_summary>The primary objective study explore hospitalization ( number , length reason psychiatric hospitalization ) young , adult , newly diagnose schizophrenia participant first 12 month treatment monthly paliperidone palmitate naturalistic clinical setting .</brief_summary>
	<brief_title>Non-Interventional Study Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate</brief_title>
	<detailed_description>This retrospective , non-interventional , multicenter study retrospectively evaluate hospitalization medical resource use , pattern paliperidone palmitate use , clinical outcome document within medical record young , adult , newly diagnose schizophrenia participant first 12 month continuous treatment paliperidone palmitate . Only retrospective data available clinical routine practice document participant 's medical record collect . The study conduct country within EMEA region paliperidone palmitate approve available . The study consider complete last data collection last participant participate study .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Participant must man woman age least 18 year 29 year time first injection paliperidone palmitate Participant must document diagnosis schizophrenia accord either Tenth Revision International Classification Diseases Related Health Problems ( ICD 10 ) Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM 4 ) Participant 's first psychotic episode suggestive schizophrenia must clinically evident longer 1 year prior first injection paliperidone palmitate Participant must documentation ( medical record ) least 12 month ( 365 +/ 31 day ) continuous treatment paliperidone palmitate administer first time part clinical practice . This documentation must complete participant 's record initiation study site Participant must initiate paliperidone palmitate treatment launch date ( ie , commercial availability ) paliperidone palmitate his/her respective site Participant either ICD 10 DSM 4 axis I diagnosis schizophrenia Participant diagnose alcohol drug dependence ( except nicotine caffeine dependence ) accord either ICD 10 DSM 4 criterion within 1 month prior initiation paliperidone palmitate treatment 12 month documentation period Participant treat long act injectable antipsychotic prior paliperidone palmitate initiation longacting injectable antipsychotic paliperidone palmitate 12 month documentation period Participant receive investigational drug ( include investigational vaccine ) use invasive investigational medical device within 30 day prior paliperidone palmitate initiation 12 month documentation period Participant participate interventional noninterventional clinical study 12 month documentation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Paliperidone palmitate</keyword>
</DOC>